Showing results (1-10 of 282) with videos related to

Sort By:
Pageof 29
Journal of AIDS & Clinical Research|March 4, 2017
Microarrays-Enabled Hypothesis Generation: The Suspect Role of FNBP-1 in Neuropsychiatric Pathogenesis Associated with HIV and/or HCV InfectionA Katsounas, K R Wilting, R A Lempicki, et al.
Journal of Hepatology|February 12, 1998
Chronic hepatitis C: the viral load per liver cell before treatment as a new marker to predict long-term response to IFN-alpha therapyJ F Schlaak, M Trippler, I Ernst, et al.
Journal of Medical Virology|September 24, 1998
Interleukin 12 enhances deficient HCV-antigen-induced Th1-type immune response of peripheral blood mononuclear cellsJ F Schlaak, T Pitz, H F Löhr, et al.
Clinical and Experimental Immunology|April 8, 1999
HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokinesJ F Schlaak, G Tully, H F Löhr, et al.
Journal of Hepatology|April 6, 1999
The presence of high amounts of HBV-DNA in serum is associated with suppressed costimulatory effects of interleukin 12 on HBV-induced immune responseJ F Schlaak, G Tully, H F Löhr, et al.
Zeitschrift Fur Gastroenterologie|June 7, 2014
Tacrolimus as a reasonable alternative in a patient with steroid-dependent and thiopurine-refractory autoimmune pancreatitis with IgG4-associated cholangitisM Buechter, C Georg Klein, C Kloeters, et al.
Journal of Viral Hepatitis|April 23, 2014
Long-term stimulation of Toll-like receptor 3 in primary human hepatocytes leads to sensitization for antiviral responses induced by poly I:C treatmentR Broering, M Lutterbeck, M Trippler, et al.
Journal of Hepatology|November 21, 1998
The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcomeH F Löhr, G Gerken, M Roth, et al.
Journal of Viral Hepatitis|February 7, 2014
Toll-like receptor-mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigenM Jiang, R Broering, M Trippler, et al.
Journal of Viral Hepatitis|January 14, 2012
CCL5 mRNA is a marker for early fibrosis in chronic hepatitis C and is regulated by interferon-α therapy and toll-like receptor 3 signallingA Katsounas, M Trippler, B Wang, et al.
Pageof 29